(MedPage Today) — DENVER — Targeting an inflammatory pathway in diabetic macular edema (DME), in addition to angiogenesis, led to greater improvement in visual acuity and retinal anatomy, a randomized trial showed.
Single-agent ranibizumab…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
